The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 15 Nov 2005
doi: 10.1242/jcs.02674
Research Article
Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis
U. Ruth Michaelis,
Beate Fisslthaler,
Eduardo Barbosa-Sicard,
John R. Falck,
Ingrid Fleming*,
and
Rudi Busse
* Author for correspondence (e-mail: fleming{at}em.uni-frankfurt.de)
Recent studies suggest that cytochrome P450 (CYP) epoxygenase-derived epoxyeicosatrienoic acids (EETs) elicit cell proliferation and promote angiogenesis. The aim of this study was to determine the role of CYP 2C8/9-derived EETs in the process of angiogenesis under hypoxic conditions. In human endothelial cells, hypoxia enhanced the activity of the CYP 2C9 promoter, increased the expression of CYP 2C mRNA and protein and augmented 11,12-EET production. In Transwell assays, the migration of endothelial cells pre-exposed to hypoxia to increase CYP expression was abolished by CYP 2C antisense oligonucleotides as well as by the CYP inhibitor MS-PPOH and the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (EEZE). Similar findings were obtained in porcine coronary artery endothelial cells. CYP 2C9 overexpression in endothelial cells increased the association of PAK-1 with Rac, a response also elicited by the CYP 2C9 product 11,12-EET. Matrix metalloprotease (MMP) activity was increased in CYP-2C9-overexpressing cells and correlated with increased invasion through Matrigel-coated Transwell chambers: an effect sensitive to the CYP 2C9 inhibitor sulfaphenazole as well as to EEZE and the MMP inhibitor GM6001. In in vitro angiogenesis models, the EET antagonist inhibited tube formation induced by CYP 2C9 overexpression as well as that in endothelial cells exposed to hypoxia to increase CYP 2C expression. Furthermore, in the chick chorioallantoic membrane assay, EEZE abolished hypoxia-induced angiogenesis. Taken together, these data indicate that CYP 2C-derived EETs significantly affect the sequence of angiogenic events under hypoxic conditions.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. D. Fisher, A. J. Lickteig, L. M. Augustine, J. Ranger-Moore, J. P. Jackson, S. S. Ferguson, and N. J. Cherrington
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
Drug Metab. Dispos.,
October 1, 2009;
37(10):
2087 - 2094.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Keseru, E. Barbosa-Sicard, R. T. Schermuly, H. Tanaka, B. D. Hammock, N. Weissmann, B. Fisslthaler, and I. Fleming
Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition
Cardiovasc Res,
September 4, 2009;
(2009)
cvp281v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Giannarelli, A. Virdis, F. De Negri, A. Magagna, E. Duranti, A. Salvetti, and S. Taddei
Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients
Circulation,
March 31, 2009;
119(12):
1625 - 1633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Keseru, E. Barbosa-Sicard, R. Popp, B. Fisslthaler, A. Dietrich, T. Gudermann, B. D. Hammock, J. R. Falck, N. Weissmann, R. Busse, et al.
Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response
FASEB J,
December 1, 2008;
22(12):
4306 - 4315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Webler, U. R. Michaelis, R. Popp, E. Barbosa-Sicard, A. Murugan, J. R. Falck, B. Fisslthaler, and I. Fleming
Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1292 - C1301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R. C. Venema, and G. N. Rao
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis
Blood,
June 15, 2008;
111(12):
5581 - 5591.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Webler, R. Popp, T. Korff, U. R. Michaelis, C. Urbich, R. Busse, and I. Fleming
Cytochrome P450 2C9-Induced Angiogenesis Is Dependent on EphB4
Arterioscler Thromb Vasc Biol,
June 1, 2008;
28(6):
1123 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. R. Michaelis, N. Xia, E. Barbosa-Sicard, J. R. Falck, and I. Fleming
Role of Cytochrome P450 2C Epoxygenases in Hypoxia-Induced Cell Migration and Angiogenesis in Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
March 1, 2008;
49(3):
1242 - 1247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau
EET Displays Anti-Inflammatory Effects in TNF-{alpha} Stimulated Human Bronchi: Putative Role of CPI-17
Am. J. Respir. Cell Mol. Biol.,
February 1, 2008;
38(2):
192 - 201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wray and D. Bishop-Bailey
Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology
Exp Physiol,
January 1, 2008;
93(1):
148 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Nusing, H. Schweer, I. Fleming, D. C. Zeldin, and M. Wegmann
Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F288 - F298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau
Epoxyeicosatrienoic Acid Relaxing Effects Involve Ca2+-Activated K+ Channel Activation and CPI-17 Dephosphorylation in Human Bronchi
Am. J. Respir. Cell Mol. Biol.,
May 1, 2007;
36(5):
633 - 641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. DeLozier, G. E. Kissling, S. J. Coulter, D. Dai, J. F. Foley, J. A. Bradbury, E. Murphy, C. Steenbergen, D. C. Zeldin, and J. A. Goldstein
Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular Tissues
Drug Metab. Dispos.,
April 1, 2007;
35(4):
682 - 688.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol,
March 1, 2007;
292(3):
C996 - C1012.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. B. Campbell and J. R. Falck
Arachidonic Acid Metabolites as Endothelium-Derived Hyperpolarizing Factors
Hypertension,
March 1, 2007;
49(3):
590 - 596.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Fisslthaler, I. Fleming, B. Keseru, K. Walsh, and R. Busse
Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1
Circ. Res.,
February 2, 2007;
100(2):
e12 - e21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Fleming and R. Busse
Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function
Hypertension,
April 1, 2006;
47(4):
629 - 633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pokreisz, I. Fleming, L. Kiss, E. Barbosa-Sicard, B. Fisslthaler, J. R. Falck, B. D. Hammock, I.-H. Kim, Z. Szelid, P. Vermeersch, et al.
Cytochrome P450 Epoxygenase Gene Function in Hypoxic Pulmonary Vasoconstriction and Pulmonary Vascular Remodeling
Hypertension,
April 1, 2006;
47(4):
762 - 770.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
